Efectul melatoninei la femelele de şobolan ovarectomizate asupra proliferǎrii endometrului

Gineco.ro

Volumn 6, Issue 1, 2010, Pages 47-55

  Ciortea, R ^a   Costin, N ^a   Groza, Daria Maria ^a   Mocan, R ^a   Susman S ^a   Bondor, Cosmina ^a   Mihu, Carmen Mihaela ^a   Mihu, D ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Cancer; Endometrial proliferation; Melatonin; Rats

Indexed keywords

ESTROGEN; MELATONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ENDOMETRIUM CANCER; ESTROGEN THERAPY; FEMALE; INTERMETHOD COMPARISON; MENOPAUSE; NONHUMAN; PROPHYLAXIS; SUPPLEMENTATION; TREATMENT DURATION;

EID: 79955681974     PISSN: 18414435     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. A.S. Greenberg, M.S. Obin. Obesity and the rol of adipose tissue in inflamation and metabolism. The Am. J. of CliClnical Nutrition 2006;2:112-116.
2. Kanishi Y., Kobayashi Y., Noda S., Ishizuka B., Saito K: Differential growth inhibitory effect of melatonin on two endometrial cancer cell lines.J Pineal Res.2000;28(4):227-33.
3. Stevens R.G., Rea M.S.: Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Control. 2001;12:279-287. (Pubitemid 32515375)
4. Blask D.E., Dauchy R.T., Sauer L.A., Krause J.A., Brainard G.C.:Growth and fatty acid metabolism of human breast cancer(MCF-7) xenografts in nude rats: impact of constant light induced nocturnal melatonin suppression. Breast Cancer Res Treat. 2003;79:313-320. (Pubitemid 36750938)
5. Farriol M., Venereo Y., Orta X., Castellanos J.M., Segovia-Silvestre T.:In vitro effects of melatonin on cell proliferation in a colon adenocarcinoma line.J Appl Toxicol. 2000; 20(1):21-4.
6. Sainz R.M., Mayo J.C., Tan D.X., León J., Manchester L., Reiter R.J.: Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism.Prostate. 2005;63(1):29-43.
7. Walker M.J., Chaudhuri P.K., Beattie C.W., et al: Neuroendocrine and endocrine correlates to hamster melanoma growth in vitro. Surg Forum. 1998. 29:151-152.
8. Karasek M., Kowalski A.J., Zylinska K. Serum melatonin circadian profile in women suffering from the genital tract cancers.Neuro Endocrinol Lett. 2000;21(2):109-113.
9. Kanishi Y., Kobayashi Y., Noda S., Ishizuka B., Saito K: Differential growth inhibitory effect of melatonin on two endometrial cancer cell lines.J Pineal Res.2000;28(4):227-33.
10. Gerdin M.J.,Masana M.I.,Dubocovich M.L.:Melatonin-mediated regulation of human MT(1) melatonin receptors expressed in mammalian cells.Biochem Pharmacol.2004;67(11):2023-30.
11. Wolden-Hanson T, Mitton DR, McCants RL, Yellon SM, Wilkinson CW, Matsumoto AM, Rasmussen DD Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology 2000;141(2):487-97. (Pubitemid 32250470)
12. Puchalski SS, Green JN, Rasmussen DD Melatonin effect on rat body weight regulation in response to high-fat diet at middle age Endocrine 2003;21(2):163-7.
13. Rasmussen DD, Boldt BM, Wilkinson CW, Yellon SM, Matsumoto AM Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels Endocrinology 2002;143(4):1269.
14. Bray G.A., The Underlying Basis for Obesity: Relationship to Cancer, Journal of American. Society for Nutrition Sciences 2002;3451S-3455S.
15. Francesmary M, Ness R.B., Chu Chen, Weis N.S., Inflamation and Endometrial Cancer:A Hypotesis, Cancer Epidemiol Biomarkers & Prev 2005;12:2840-2847.
16. Speake BK, Parkin SM, Robinson DS Degradation of lipoprotein lipase in rat adipose tissue.Biochim Biophys Acta. 1984;840(3):419-22.
17. Kahn HS The accumulation of visceral adipose tissue may be influenced by intra-abdominal temperature Obes Res. 1996;4(3):297-9.